Detalhe da pesquisa
1.
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
Int J Cancer
; 145(8): 2114-2121, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901076
2.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603996
3.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
BMC Cancer
; 19(1): 611, 2019 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227025
4.
Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer Patients.
Breast Care (Basel)
; 14(3): 159-164, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31316314
5.
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
J Natl Cancer Inst
; 110(6): 628-637, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29228315
6.
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Integr Cancer Ther
; 16(2): 165-175, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27627986
7.
Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Crit Rev Oncol Hematol
; 58(2): 166-75, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16387512
8.
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Breast Care (Basel)
; 11(5): 315-322, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27920623
9.
Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.
Acta Oncol
; 44(3): 248-54, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16076697